Anshul Mangal

Opinion author

Anshul Mangal is a biotech entrepreneur, experienced executive, board member, philanthropist and attorney. He is the president of Project Farma, Precision for Medicine’s Manufacturing Solutions. He is also a board member at the Alliance for Regenerative Medicines, Alliance for mRNA Medicines and IQHQ.

Pictured: Supreme Court building/Courtesy Adobe St

Opinion

The End of Chevron Deference Could Open a New Era of Biotech

While the full impact of the Supreme Court decision remains unknown, the new regulatory landscape could be a net positive for drug developers.

November 20, 2024

6 min read

Anshul Mangal

Biopharma collage of scientist, deals, and pills

Opinion

When Should Biopharma Companies Buy, Partner or Develop Innovative Assets?

Here’s how to assess whether to develop a new therapy by building a proprietary platform, acquiring another company or asset or partnering with an established entity.

April 24, 2024

6 min read

Anshul Mangal